Skip to search formSkip to main contentSkip to account menu

Transaction counts and value totals - month

Known as: month 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Phase III, randomized, double blind, placebo-controlled trial of sorafenib in desmoid tumors (Alliance A091105).
11500Background: DT is a rare cancer of connective tissue affecting young patients (pts), arising in any location, with a wide… 
2017
2017
Updated efficacy, safety, and biomarker analyses of STEAM, a randomized, open-label, phase II trial of sequential (s) and concurrent (c) FOLFOXIRI-bevacizumab (BV) vs FOLFOX-BV for first-line (1L…
657Background: STEAM (NCT01765582) assessed efficacy and safety of 1L cFOLFOXIRI-BV and sFOLFOXIRI-BV vs FOLFOX-BV. Updated… 
2017
2017
NCCTG N1174: Phase I/comparative randomized phase (Ph) II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma (GBM) (Alliance).
2023Background: TRC105 is a humanized antibody targeting CD105 (endoglin), a member of the TGFβ receptor superfamily. CD105 is… 
Review
2017
Review
2017
Management of Chronic Myeloid Leukemia (CML) during Pregnancy Among Patients (pts) Treated with a Tyrosine Kinase Inhibitor (TKI): A Single-Center Experience
Background: Exposure to TKI has teratogenic effects in animal studies and humans. CML is being identified in younger patients who… 
2011
2011
The incidence of BCR-ABL mutations in patients (pts) with newly diagnosed chronic myeloid leukemia (CML) in chronic phase (CP) treated with nilotinib or imatinib in ENESTnd: 24-month follow-up.
6502 Background: In ENESTnd, nilotinib has demonstrated superior efficacy vs imatinib in newly diagnosed CML-CP pts. Baseline (BL… 
2011
2011
P2-18-02: Cardiac Outcomes of Patients on Adjuvant Weekly Paclitaxel (T) and Trastuzumab (H) for Node Negative, HER2 Positive Breast Cancer (BCA).
Background Patients (pts) with (w/) node-negative HER2−positive BCA have a higher risk of recurrence than those with node… 
2009
2009
A phase II trial of salirasib in patients with stage IIIB/IV lung adenocarcinoma enriched for KRAS mutations.
8012 Background: KRAS mutations are present in 30% of lung adenocarcinomas and are associated with primary resistance to… 
2005
2005
Effect of troglitazone on the desaturases in a rat model of insulin-resistance induced by a sucrose-rich diet.
2000
2000
3722 Endoscopic ultrasound predictors of long term survival in esophageal carcinoma.
1999
1999
Prognostic relevance of monosomy at the 13q14 locus detected by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)